| Targeting the bone marrow microenvironment in multiple myeloma Y Kawano, M Moschetta, S Manier, S Glavey, GT Görgün, AM Roccaro, ... Immunological reviews 263 (1), 160-172, 2015 | 379 | 2015 |
| Engineered nanomedicine for myeloma and bone microenvironment targeting A Swami, MR Reagan, P Basto, Y Mishima, N Kamaly, S Glavey, S Zhang, ... Proceedings of the National Academy of Sciences 111 (28), 10287-10292, 2014 | 281 | 2014 |
| Prognostic role of circulating exosomal miRNAs in multiple myeloma S Manier, CJ Liu, H Avet-Loiseau, J Park, J Shi, F Campigotto, KZ Salem, ... Blood, The Journal of the American Society of Hematology 129 (17), 2429-2436, 2017 | 262 | 2017 |
| Inhibitory effect of leptin on human uterine contractility in vitro AT Moynihan, MP Hehir, SV Glavey, TJ Smith, JJ Morrison American journal of obstetrics and gynecology 195 (2), 504-509, 2006 | 257 | 2006 |
| CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal-transition-like transcriptional activation AM Roccaro, Y Mishima, A Sacco, M Moschetta, YT Tai, J Shi, Y Zhang, ... Cell reports 12 (4), 622-635, 2015 | 136 | 2015 |
| The cancer glycome: carbohydrates as mediators of metastasis SV Glavey, D Huynh, MR Reagan, S Manier, M Moschetta, Y Kawano, ... Blood reviews 29 (4), 269-279, 2015 | 127 | 2015 |
| Role of endothelial progenitor cells in cancer progression M Moschetta, Y Mishima, I Sahin, S Manier, S Glavey, A Vacca, ... Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1846 (1), 26-39, 2014 | 125 | 2014 |
| Investigating osteogenic differentiation in multiple myeloma using a novel 3D bone marrow niche model MR Reagan, Y Mishima, SV Glavey, Y Zhang, S Manier, ZN Lu, ... Blood, The Journal of the American Society of Hematology 124 (22), 3250-3259, 2014 | 122 | 2014 |
| The sialyltransferase ST3GAL6 influences homing and survival in multiple myeloma SV Glavey, S Manier, A Natoni, A Sacco, M Moschetta, MR Reagan, ... Blood, The Journal of the American Society of Hematology 124 (11), 1765-1776, 2014 | 120 | 2014 |
| Von Willebrand factor propeptide in severe coronavirus disease 2019 (COVID‐19): evidence of acute and sustained endothelial cell activation SE Ward, GF Curley, M Lavin, H Fogarty, E Karampini, NL McEvoy, ... British journal of haematology 192 (4), 714-719, 2021 | 108 | 2021 |
| Antibody-dependent cellular phagocytosis by macrophages is a novel mechanism of action of elotuzumab AT Kurdi, SV Glavey, NA Bezman, A Jhatakia, JL Guerriero, S Manier, ... Molecular cancer therapeutics 17 (7), 1454-1463, 2018 | 92 | 2018 |
| Proteomic characterization of human multiple myeloma bone marrow extracellular matrix SV Glavey, A Naba, S Manier, K Clauser, S Tahri, J Park, MR Reagan, ... Leukemia 31 (11), 2426-2434, 2017 | 87 | 2017 |
| The LIN28B/let-7 axis is a novel therapeutic pathway in multiple myeloma S Manier, JT Powers, A Sacco, SV Glavey, D Huynh, MR Reagan, ... Leukemia 31 (4), 853-860, 2017 | 83 | 2017 |
| Monoclonal gammopathy: The good, the bad and the ugly SV Glavey, N Leung Blood reviews 30 (3), 223-231, 2016 | 82 | 2016 |
| Pyk2 promotes tumor progression in multiple myeloma Y Zhang, M Moschetta, D Huynh, YT Tai, Y Zhang, W Zhang, Y Mishima, ... Blood, The Journal of the American Society of Hematology 124 (17), 2675-2686, 2014 | 72 | 2014 |
| Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma S Manier, D Huynh, YJ Shen, J Zhou, T Yusufzai, KZ Salem, RY Ebright, ... Science translational medicine 9 (389), eaal2668, 2017 | 68 | 2017 |
| ADAMTS13 regulation of VWF multimer distribution in severe COVID‐19 SE Ward, H Fogarty, E Karampini, M Lavin, S Schneppenheim, R Dittmer, ... Journal of Thrombosis and Haemostasis 19 (8), 1914-1921, 2021 | 66 | 2021 |
| A detailed evaluation of the current renal response criteria in AL amyloidosis: is it time for a revision? N Leung, SV Glavey, S Kumar, A Dispenzieri, FK Buadi, D Dingli, ... Haematologica 98 (6), 988, 2013 | 61 | 2013 |
| Targeting vasculogenesis to prevent progression in multiple myeloma M Moschetta, Y Mishima, Y Kawano, S Manier, B Paiva, L Palomera, ... Leukemia 30 (5), 1103-1115, 2016 | 55 | 2016 |
| AKT as a therapeutic target in multiple myeloma NA Keane, SV Glavey, J Krawczyk, M O’Dwyer Expert opinion on therapeutic targets 18 (8), 897-915, 2014 | 52 | 2014 |
